Group 1 - The company, Weigao Blood Purification, has initiated a public offering with a total issuance of 41.1394 million shares, including 11.1075 million shares for online subscription at a price of 26.50 yuan per share, with an issuance price-to-earnings ratio of 24.82 times [1][3] - The maximum subscription limit for a single account is set at 11,000 shares, with subscriptions required to be in multiples of 500 shares [1][3] - The funds raised will be allocated to various projects, including 400 million yuan for working capital, 342 million yuan for intelligent production construction, and 28.5 million yuan for a new high-performance consumables R&D center [3] Group 2 - The company specializes in the research, production, and sales of medical products for blood purification [2] - Key financial indicators for the company show total assets of 69.90 billion yuan in 2024, a net profit of 4.49 billion yuan, and a basic earnings per share of 1.21 yuan [3]
威高血净今日申购 顶格申购需配市值11万元
Zheng Quan Shi Bao Wang·2025-05-08 01:33